**Question:** Rofecoxib as compared to indomethacin is:

A. More effective in treating osteoarthritis symptoms
B. Less likely to cause gastrointestinal side effects
C. More likely to cause cardiovascular events
D. More effective in treating rheumatoid arthritis symptoms

**Core Concept:**

Rofecoxib and indomethacin are nonsteroidal anti-inflammatory drugs (NSAIDs), which are commonly used to alleviate pain, inflammation, and swelling associated with various conditions such as osteoarthritis, rheumatoid arthritis, and other inflammatory disorders. These drugs work by inhibiting the production of prostaglandins, which are substances involved in pain and inflammation. Both rofecoxib and indomethacin share this mechanism of action.

**Why the Correct Answer is Right:**

Rofecoxib is a selective COX-2 inhibitor, meaning it preferentially inhibits the cyclooxygenase-2 (COX-2) enzyme, which is primarily responsible for prostaglandin synthesis in the inflammatory process. This selective inhibition reduces the risk of gastrointestinal side effects, as indomethacin, a non-selective COX inhibitor, also inhibits COX-1, leading to increased risk of gastrointestinal complications.

**Why Each Wrong Option is Incorrect:**

A. The statement "More effective in treating osteoarthritis symptoms" is incorrect because rofecoxib and indomethacin are equally effective in treating osteoarthritis symptoms due to their shared mechanism of action as NSAIDs.

B. The statement "Less likely to cause gastrointestinal side effects" is correct for rofecoxib but not for indomethacin. As mentioned before, rofecoxib is selective COX-2 inhibitor, reducing the risk of gastrointestinal side effects compared to indomethacin, a non-selective COX inhibitor.

C. The statement "More likely to cause cardiovascular events" is incorrect for both drugs, as the association between COX-2 inhibitors and increased cardiovascular risk is a misconception. COX-2 inhibitors have been found to have a lower risk of cardiovascular complications compared to nonselective NSAIDs like indomethacin.

D. The statement "More effective in treating rheumatoid arthritis symptoms" is incorrect, as both drugs are equally effective in treating rheumatoid arthritis symptoms due to their shared mechanism of action as NSAIDs.

**Clinical Pearl:**

Selective COX-2 inhibitors like rofecoxib and other COX-2 inhibitors are generally considered safer than nonselective NSAIDs like indomethacin in terms of gastrointestinal side effects. However, the choice between them depends on the specific condition and patient risk profile. For example, in patients with a history of gastrointestinal ulcers or bleeding, a selective COX-2 inhibitor may be a safer choice due to its reduced gastrointestinal side effects. On the other hand, nonselective NSAIDs like indomethacin may be preferred for patients who have a higher risk of cardiovascular events due to their lower risk of cardiovascular complications. The choice between selective and nonselective NSAIDs is patient-specific and depends on their risk profile and the